Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.

Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Ital ...

Cocaine-induced leukoencephalopathy is a rare neurological condition usually associated with substances used to adulterate ...

ongoing clinical updates anticipated throughout 2025 - Received regulatory clearance of IND from the U.S. FDA to expand ELIMINATE-B trial and CTA approved by MHRA for study expansion into the UK.

Shanghai Electric (SEHK:2727, SSE:601727) once again impresses visitors at  this year's Intersolar Europe, the world's leading exhibition for the solar industry, held in Munich from May 7-9. The ...

Regional trends driving innovation and demand across key veterinary sectors.” — Sabyasachi Ghosh, Principal Consultant.

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, today ...

The Red Line extension now carries a $5.75B price tag — raising questions about CTA debt, cost overruns, and whether the project is still worth it.

Between administration changes, court appeals, and Congressional oversight, the Corporate Transparency Act remains in limbo ...

Ward Ald. David Moore defended Johnson’s rumored pick for CTA president and told board members not to be a “backbiting snake.

Station group chief discusses the evolution and future of datacasting over ATSC 3.0 ...